# Acotiamide vs Itopride in Postprandial Distress Syndrome

> **NCT07174297** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Getz Pharma** · enrollment: 152 (estimated)

## Conditions studied

- Postprandial Distress Syndrome

## Interventions

- **DRUG:** Acotiamide

## Key facts

- **NCT ID:** NCT07174297
- **Lead sponsor:** Getz Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-30
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-04-30
- **Target enrollment:** 152 (ESTIMATED)
- **Last updated:** 2025-09-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07174297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07174297, "Acotiamide vs Itopride in Postprandial Distress Syndrome". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT07174297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*